This Thanksgiving, we're grateful for the clinicians, partners, and patients who inspire progress every day. Thank you for your trust, collaboration and care. Wishing you a meaningful holiday filled with gratitude. #Thankful #Gratitude #PatientCare

Where does leadless LVEP fit into CRT pathways today? Join us on 11/22 at 5:30 pm ET at #RIO2025 to explore clinical rationale, patient selection, workflow integration & real case outcomes. Register: https://t.co/1QUmtZtZfM

Leadless LVEP is redefining CRT. Join a case review + live panel at #RIO2025 on 11/22 at 5:30 pm ET to explore endocardial rationale, workflow integration, outcomes & procedural sights. 📅 Register now: https://t.co/1QUmtZtZfM

Today we honor and thank all Veterans for their service, courage, and sacrifice. Your commitment inspires us every day. #VeteransDay

Congrats to @Drdevignair and team on completing the first WiSE-UP Study enrollments - advancing real-world evidence for the WiSE® System. Learn more: https://t.co/DHta76VnQK

New OUS studies explore investigational uses for the WiSE® System: 1️⃣ Totally Leadless CSP 2️⃣ CRT for non-responders These off-label applications aren't FDA-approved but point to future investigations. Read more: https://t.co/40KK159QTn eIFU & ISI: https://t.co/rESYPDpLMc

Big news from EBR: CMS has finalized NTAP and TPT reimbursement for the WiSE System, effective Oct 1, 2025 — marking a major step toward expanding access to leadless LV endocardial pacing (LVEP) in the U.S. 🔗 Learn more: https://t.co/2LmBaU3rHI eIFU: https://t.co/rESYPDpLMc

Here's some cool science for you: A device the size of a grain of rice that can help your heart beat in sync with your pacemaker. https://t.co/kENVZzUgKG

65-year-old Tom Derrington was running out of options. After receiving the WiSE System at St. David’s TCAI, he’s back to walking trails & even light construction work. Read his inspiring story: https://t.co/fdHMQc9Arw ISI:

Innovation in cardiac care changes lives. Watch how WiSE transformed David’s life in Naples, FL.: https://t.co/rYTRHiGqRL View approved indications & ISI:

Congratulations to Fogarty company-in-residence, @Materna_Medical on the completion of a recent close within an ongoing $20 million Series B2 round & the new commercial name for its second product, Ellora™ (formerly Materna Prep)! More: https://t.co/t7fq3lPq6n

Vital Signs Podcast: @EBRSystemsInc major milestones in WiSE CRT commercialisation https://t.co/ZTbpy9QGii #ASX #Medtech $EBR

Vital Signs Podcast: EBR’s major milestones in WiSE CRT commercialisation

First U.S. commercial implants of the FDA-approved WiSE System are complete—thanks to 🫀 Dr. Robert Canby + team at @StDavidsHC 🫀 Dr. Niraj Varma @ClevelandClinic Leadless LVEP is here for heart failure patients who had no other options. Press Release:

Break it Down: @EBRSystemsInc completes first US commercial implants of WiSE CRT system. Watch the video here: https://t.co/P8ZkT0FSbv #ASX #Medtech $EBR

Please share this opportunity with colleagues and friends! The Fogarty Prize recognizes an individual or team who has developed and commercialized a singular medical technology that has meaningfully advanced patient care. #medtech #innovation #impact

As #HRS2025 ends, we proudly celebrate FDA approval of the WiSE System—a major step for cardiac care. Thank you to everyone who supported us and visited this week to experience the future of CRT. Let’s keep driving patient innovation forward. #LVEP #epeeps 💙

💡 FDA-approved and leadless: The WiSE System delivers LV endocardial pacing without a CS lead. Experience the system and try the simulator at Booth 2526. #HRS2025 #LVEP